Approval for the resolute integrity zotarolimus-eluting coronary stent system. this device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, withsymptomatic ischemic heart disease due to de novo lesions of length <= 35 mm in native coronary arteries with reference vessel diameters of  2.25 mm to 4.2 mm.